FORUS Therapeutics is a Canadian biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer.
Our mission is to bring health solutions to Canadian cancer patients, physicians, caregivers and the many partners and stakeholders that support them. Our goal is to accelerate unique and important treatments that meaningfully enhance life.
Company Details
- Employees
- 15
- Founded
- 2020
- Address
- 200 N Service Rd W, Suite 129,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://forustherapeutics.com
- Keywords
- Rd W.
- HQ
- Oakville, Ontario
Forus Therapeutics Inc Questions
Forus Therapeutics Inc's website is https://forustherapeutics.com
Forus Therapeutics Inc's LinkedIn profile is https://ca.linkedin.com/company/forus-therapeutics
Forus Therapeutics Inc has
15 employees.
View email and phone details for 15
employees at Forus Therapeutics Inc.
Forus Therapeutics Inc's industry is
Biotechnology Research
Forus Therapeutics Inc's top competitors are
Juno Pharma Canada Inc.,
Abdera Therapeutics,
Karyopharm Therapeutics Inc.,
Pharmaessentia,
Neurasic Therapeutics Inc,
Feldan Therapeutics ǀ Feldan Thérapeutiques,
Virica Biotech,
Admare Bioinnovations,
Reverb Therapeutics,
Cipher Pharmaceuticals Inc. (Tsx: Cph) (Otcqx:cphrf).
Forus Therapeutics Inc's categories are Biotechnology Research
Forus Therapeutics Inc's founding year is 2020
